Cargando…
An Exceedingly Rare Case of Liraglutide-Induced Liver Injury
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.
Autores principales: | Parvataneni, Swetha, Ramachandran, Rajarajeshwari, Then, Eric, Grantham, Tyler, Gaduputi, Vinaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405313/ https://www.ncbi.nlm.nih.gov/pubmed/34471551 http://dx.doi.org/10.1155/2021/6306149 |
Ejemplares similares
-
Pyloric Stenosis: A Rare Manifestation of Crohn’s Disease
por: Ramachandran, Rajarajeshwari, et al.
Publicado: (2022) -
COVID-19-Associated Ischemic Colitis: A Rare Manifestation of COVID-19 Infection—Case Report and Review
por: Uhlenhopp, Dustin J., et al.
Publicado: (2022) -
Stomach Within a Large Inguinal Hernia
por: Grantham, Tyler A, et al.
Publicado: (2022) -
Metastatic Gastric Cancer to the Colon
por: Then, Eric Omar, et al.
Publicado: (2021) -
Rare Hematological Disease of Paroxysmal Nocturnal Hemoglobinuria With Profound Implications for a Gastroenterologist: A Case Report and Literature Review
por: Parvataneni, Swetha, et al.
Publicado: (2020)